Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03714438Phase 2Completed
Phase 2, randomised, double-blind trial (2 arms), sponsored by Universidad de Guadalajara. Primary endpoints: Fasting Plasma Glucose, 2-hour Post-load Glucose and 3 more. Started Feb 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03714438.